185,589 Shares in Aspen Aerogels, Inc. $ASPN Acquired by Palogic Value Management L.P.

Palogic Value Management L.P. acquired a new stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 185,589 shares of the construction company’s stock, valued at approximately $1,177,000.

Several other hedge funds have also recently made changes to their positions in ASPN. Royal Bank of Canada grew its stake in shares of Aspen Aerogels by 84.7% during the 1st quarter. Royal Bank of Canada now owns 56,419 shares of the construction company’s stock worth $360,000 after acquiring an additional 25,880 shares during the period. AQR Capital Management LLC bought a new stake in Aspen Aerogels in the 1st quarter valued at about $960,000. Integrated Wealth Concepts LLC purchased a new stake in Aspen Aerogels during the first quarter valued at about $84,000. Goldman Sachs Group Inc. boosted its position in Aspen Aerogels by 89.7% during the first quarter. Goldman Sachs Group Inc. now owns 1,274,356 shares of the construction company’s stock worth $8,143,000 after purchasing an additional 602,586 shares during the period. Finally, Caxton Associates LLP bought a new position in Aspen Aerogels during the first quarter worth about $307,000. 97.64% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts recently commented on ASPN shares. Wall Street Zen cut shares of Aspen Aerogels from a “hold” rating to a “sell” rating in a research note on Saturday, August 15th. B. Riley Financial reissued a “buy” rating on shares of Aspen Aerogels in a report on Friday, August 7th. Weiss Ratings restated a “sell (d-)” rating on shares of Aspen Aerogels in a research report on Wednesday, June 24th. Barclays raised their price target on Aspen Aerogels from $4.00 to $5.00 and gave the stock an “underweight” rating in a report on Tuesday, August 11th. Finally, Roth Capital restated a “buy” rating and issued a $7.75 target price on shares of Aspen Aerogels in a research note on Friday, August 7th. Four equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, Aspen Aerogels presently has an average rating of “Hold” and an average price target of $5.94.

Aspen Aerogels Stock Performance

NYSE ASPN opened at $5.21 on Thursday. The company’s 50 day simple moving average is $5.45 and its two-hundred day simple moving average is $4.63. The company has a debt-to-equity ratio of 0.36, a current ratio of 2.52 and a quick ratio of 2.24. Aspen Aerogels, Inc. has a 1 year low of $2.30 and a 1 year high of $9.35. The stock has a market capitalization of $432.38 million, a PE ratio of -3.41 and a beta of 2.99.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings data on Thursday, August 6th. The construction company reported ($0.22) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.23) by $0.01. The company had revenue of $49.85 million during the quarter, compared to analyst estimates of $42.42 million. Aspen Aerogels had a negative return on equity of 31.12% and a negative net margin of 62.45%.Aspen Aerogels has set its Q3 2026 guidance at -0.110–0.070 EPS. Analysts predict that Aspen Aerogels, Inc. will post -0.69 earnings per share for the current fiscal year.

About Aspen Aerogels

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.